Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.

Abstract

PURPOSE: We reviewed the outcome of children with medulloblastoma treated from 1970 to 1985 with combined radiotherapy and chemotherapy. PATIENTS AND METHODS: Fifty-seven children with a median age of 8 years (range 1 to 16 years) at diagnosis were analyzed regarding survival, site and time of recurrence, treatment toxicity, prognostic factors and performance status.

Authors

Whitton AC; Syndikus I; Tait DM; Bloom HJ

Journal

Strahlentherapie und Onkologie, Vol. 171, No. 11, pp. 615–621

Publication Date

November 1995

ISSN

0179-7158

Associated Experts

Anthony Whitton

Professor Emeritus, Faculty of Health Sciences

Visit profile